// App-Quantinova.ai

OP.4B.04 : URINARY PROTEOMICS PREDICTS MORTALITY IN TYPE 2 DIABETES PATIENTS WITH MICROALBUMINURIA

Researchers

Presenter

  • Currie, G

Principal Investigators

  • Von Scholten, B.J

  • Mary, S

  • Siwy, J

  • Mullen, W

  • Rossing, P

  • Delles, C

Medical Centers

  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

  • Steno Diabetes Center, Gentofte, Denmark

  • mosaiques diagnostics GmbH, Hannover, Germany,

Locations

  • United Kingdom

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved